2020

1. CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial

   Surgical Oncology, Vol. 33, pp. 224-230

2. Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)

   Clinical and Translational Oncology, Vol. 22, Núm. 7, pp. 1180-1186